Member Info for Mars1

Wonder if that was the reason focus was then on Asia as waiting for US, might be more acceptable to the big pharma now global coverage possible

Couldn’t do a global deal without it

From the RNS Sept 2018
“ This additional patent filing provides further strength and breadth to the existing NXP002 patent portfolio to best support further development and commercialisation for its NXP002 programme.”

Seem to recall this follows the latest independent test results released by Welcome Trust last week, same way German regulator approved after FIND results, so boom time for ODX

MHRA never done anything in a week.

Unlikely to be the other company if submitted on 28th May, it is only 6th June less than one week must be self test for Mologic

How soon after the FIND results did the German health regulator approve the test, will we see a repeat in the U.K. following these results.

Tricky thanks had a busy day could not go back far enough same applies approved by regulators in one EU country then applies to the rest of the EU.

So CE mark in Germany means CEmark for the whole of Europe, only need it to be approved in one EU country.

Pre production revenue fromDHSC was cost+ 18%, if we were still in pre production in May it would either be a repeat or 1/12 of the minimum production contract if phase 2 started in May. In addition we know HMG bought a small amount of antibody tests and there would be the business as usual revenue including commercial sales of antibodies.

There are a number of these contracts for rapid antibody tests awarded to Ciga. Isn’t Ciga the marketing front for ABC
https://bidstats.uk/tenders/2021/W10/746651706

Cellarboy picked this up posted by ODX on Twitter 30/4 the tests being produced at present includes an HMG test

Omega Diagnostics
@OmegaDiagnostic
·
Apr 30
In the meantime, we're using that capacity to deliver the following tests:

Rightwards arrow VISITECTRegistered sign COVID-19 Antigen
Rightwards arrow VISITECTRegistered sign CD4 Advanced Disease
Rightwards arrow AbC-19Trade mark sign COVID-19 Rapid Antibody

Along with:

Rightwards arrow A UK Government-contracted third-party #COVID19 rapid Lateral Flow Antigen

Yes not just ODX ready but Surescreen and GAD also ready which means the U.K. antigen suppliers are ready to meet HMG volumes, so the supply is ready to commence.

250k+ Buy 1700hrs declared mopping up the sales during the day for all those either having to sell or foolish enough to be impatient waiting for the inevitable demand for every single LFT that is and has been produced over the last few months.

If it is their contract has ceased no more supplies after mid June

From Gaza this is a lot of storage, contract commenced 14th May.
https://bidstats.uk/tenders/2021/W19/750780835

This is what is required more market awareness, it will make any drug maker a bit more nervous sitting on the sidelines waiting for further developments wondering if ano drug manufacturer is doing the same.

Ok thanks been busy just speed reading thought was the 2nd patent

Interesting they haven’t issued an RNS for the patent approval for the lead asset, it is quite a step forward, so it would not appear that they need to widely advertise the fact and/or not inform s/h. So are they in talks re 002 therefore keeping shtum or is it just a bespoke mail list of interested parties? As the major asset a progress update would have been expected to update the market so is something up?

Just managed a small top up after 20 attempts at NT